Chemistry:DME (psychedelic)

DME

Names
Preferred IUPAC name 2-Amino-1-(3,4-dimethoxyphenyl)ethan-1-ol
Other names 3,4-Dimethoxy-beta-hydroxyphenethylamine 3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine
Identifiers
CAS Number	6924-15-8 Y
3D model (JSmol)	Interactive image Interactive image
ChemSpider	3088871 Y
PubChem CID	3863978
UNII	F9TYB6AM4W
InChI InChI=1S/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 Y Key: WIUFFBGZBFVVDL-UHFFFAOYSA-N Y InChI=1/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 Key: WIUFFBGZBFVVDL-UHFFFAOYAL
SMILES COc1cc(ccc1OC)C(O)CN O(c1ccc(cc1OC)C(O)CN)C
Properties
Chemical formula	C10H15NO3
Molar mass	197.234 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y verify (what is YN ?)
Infobox references

Tracking categories (test):

• SizeSet

DME (3,4-dimethoxy-beta-hydroxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-hydroxy derivative of 3,4-dimethoxyphenethylamine. DME was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

See also

• Phenethylamine
• Psychedelics, dissociatives and deliriants